Eupraxia Pharmaceuticals Inc. (EPRX:TSX) closed at $11.65 on November 13, 2026, up 4.86% on the day. The stock trades 10.9% below its 52-week high of $13.08 and 48.4% above its 52-week low of $7.85. Over the past year, it gained 25.3%. Eupraxia Pharmaceuticals Inc. is part of the Health Care sector.
In 252 trading sessions since November 13, 2025, EPRX closed higher on 115 days (46%). Its best day was September 2, 2026 (+17.18%) and its worst was October 1, 2026 (-13.86%). The stock moved 10% or more in a single session 7 times. It opened at least 5% above the previous day's high 2 times.
Eupraxia Pharmaceuticals Inc is a clinical-stage biotechnology company focused on the development of locally delivered, extended-release alternatives to approved drugs. Its product candidates address therapeutic areas with a high unmet medical need and strive to provide improved patient benefit by delivering targeted, long-lasting activity with fewer side effects. Its lead product candidate, EP-104IAR, is in development for the treatment of pain due to osteoarthritis of the knee. In addition, it is developing a pipeline of earlier-stage long-acting formulations.
Find more stocks like EPRX with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.